The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dai, Z.
Right arrow Articles by Lakkis, F. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dai, Z.
Right arrow Articles by Lakkis, F. G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 1998, 161: 1659-1663.
Copyright © 1998 by The American Association of Immunologists

Impaired Alloantigen-Mediated T Cell Apoptosis and Failure To Induce Long-Term Allograft Survival in IL-2-Deficient Mice1

Zhenhua Dai*, Bogumila T. Konieczny*, Fady K. Baddoura{dagger} and Fadi G. Lakkis2,*

* The Carlos and Marguerite Mason Transplantation Research Center, Renal Division, Department of Medicine, Emory University and Veterans Affairs Medical Center, Atlanta, GA 30033; and {dagger} Pathology and Laboratory Medicine, Veterans Affairs Medical Center and State University of New York, Buffalo, NY 14215

We examined whether IL-2 regulates alloimmune responses by studying allograft survival in wild-type (IL-2+/+) and IL-2 gene-knockout (IL-2-/-) mice. The acute rejection of vascularized, cardiac allografts and the generation of allospecific CTLs were not impaired in the absence of IL-2. In contrast, blocking the B7-CD28 T cell costimulation pathway with CTLA4Ig induced long-term allograft survival (>100 days) in IL-2+/+ recipients but failed to do so in IL-2-/- mice or in wild-type mice that had been treated with IL-2-neutralizing Ab around the time of transplantation. Allografts rejected by IL-2-/- recipients exhibited extensive mononuclear cell infiltrates despite CTLA4Ig administration. In vivo allostimulation in the absence of IL-2 led to exaggerated T lymphocyte proliferation and impaired apoptosis of activated T cells in untreated and CTLA4Ig-treated mice. These findings indicate that endogenous IL-2 is required for the induction of long-term allograft survival, and that IL-2 regulates alloimmune responses by preparing activated T lymphocytes for alloantigen-induced apoptosis.




This article has been cited by other articles:


Home page
DiabetesHome page
D. Tchorsh-Yutsis, G. Hecht, A. Aronovich, E. Shezen, Y. Klionsky, C. Rosen, R. Bitcover, S. Eventov-Friedman, H. Katchman, S. Cohen, et al.
Pig Embryonic Pancreatic Tissue as a Source for Transplantation in Diabetes: Transient Treatment With Anti-LFA1, Anti-CD48, and FTY720 Enables Long-Term Graft Maintenance in Mice With Only Mild Ongoing Immunosuppression
Diabetes, July 1, 2009; 58(7): 1585 - 1594.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Mangada, T. Pearson, M. A. Brehm, L. S. Wicker, L. B. Peterson, L. D. Shultz, D. V. Serreze, A. A. Rossini, and D. L. Greiner
Idd Loci Synergize to Prolong Islet Allograft Survival Induced by Costimulation Blockade in NOD Mice
Diabetes, January 1, 2009; 58(1): 165 - 173.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. Jiang, F. Pan, L. M. Erickson, M.-S. Jang, T. Sanui, Y. Kunisaki, T. Sasazuki, M. Kobayashi, and Y. Fukui
Deletion of DOCK2, a regulator of the actin cytoskeleton in lymphocytes, suppresses cardiac allograft rejection
J. Exp. Med., October 17, 2005; 202(8): 1121 - 1130.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
B. Sawitzki, C. I. Kingsley, V. Oliveira, M. Karim, M. Herber, and K. J. Wood
IFN-{gamma} production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo
J. Exp. Med., June 20, 2005; 201(12): 1925 - 1935.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Pearson, P. Weiser, T. G. Markees, D. V. Serreze, L. S. Wicker, L. B. Peterson, A.-M. Cumisky, L. D. Shultz, J. P. Mordes, A. A. Rossini, et al.
Islet Allograft Survival Induced by Costimulation Blockade in NOD Mice Is Controlled by Allelic Variants of Idd3
Diabetes, August 1, 2004; 53(8): 1972 - 1978.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. B. Strom, L. J. Field, and M. Ruediger
Allogeneic Stem Cell-Derived "Repair Unit" Therapy and the Barriers to Clinical Deployment
J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1133 - 1139.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. H. Nelson
IL-2, Regulatory T Cells, and Tolerance
J. Immunol., April 1, 2004; 172(7): 3983 - 3988.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. G. Lakkis
Transplantation tolerance: a journey from ignorance to memory
Nephrol. Dial. Transplant., October 1, 2003; 18(10): 1979 - 1982.
[Full Text] [PDF]


Home page
J. Immunol.Home page
A. Bose, Y. Inoue, K. E. Kokko, and F. G. Lakkis
Cutting Edge: Perforin Down-Regulates CD4 and CD8 T Cell-Mediated Immune Responses to a Transplanted Organ
J. Immunol., February 15, 2003; 170(4): 1611 - 1614.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Sho, A. Yamada, N. Najafian, A. D. Salama, H. Harada, S. E. Sandner, A. Sanchez-Fueyo, X. X. Zheng, T. B. Strom, and M. H. Sayegh
Physiological Mechanisms of Regulating Alloimmunity: Cytokines, CTLA-4, CD25+ Cells, and the Alloreactive T Cell Clone Size
J. Immunol., October 1, 2002; 169(7): 3744 - 3751.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Afrouzian, V. Ramassar, J. Urmson, L.-F. Zhu, and P. F. Halloran
Transcription Factor IRF-1 in Kidney Transplants Mediates Resistance to Graft Necrosis during Rejection
J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1199 - 1209.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Rabinovitch, W. L. Suarez-Pinzon, A.M. J. Shapiro, R. V. Rajotte, and R. Power
Combination Therapy With Sirolimus and Interleukin-2 Prevents Spontaneous and Recurrent Autoimmune Diabetes in NOD Mice
Diabetes, March 1, 2002; 51(3): 638 - 645.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Sanchez-Fueyo, M. Weber, C. Domenig, T. B. Strom, and X. X. Zheng
Tracking the Immunoregulatory Mechanisms Active During Allograft Tolerance
J. Immunol., March 1, 2002; 168(5): 2274 - 2281.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. R. Jones, J. Ha, M. A. Williams, A. B. Adams, M. M. Durham, P. A. Rees, S. R. Cowan, T. C. Pearson, and C. P. Larsen
The Role of the IL-2 Pathway in Costimulation Blockade-Resistant Rejection of Allografts
J. Immunol., February 1, 2002; 168(3): 1123 - 1130.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Pimenta-Araujo, L. Mascarell, M. Huesca, A. Cumano, and A. Bandeira
Embryonic Thymic Epithelium Naturally Devoid of APCs Is Acutely Rejected in the Absence of Indirect Recognition
J. Immunol., November 1, 2001; 167(9): 5034 - 5041.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Yan, S. Shastry, C. Richards, C. Wang, D. G. Bowen, A. F. Sharland, D. M. Painter, G. W. McCaughan, and G. A. Bishop
Posttransplant Administration of Donor Leukocytes Induces Long-Term Acceptance of Kidney or Liver Transplants by an Activation-Associated Immune Mechanism
J. Immunol., April 15, 2001; 166(8): 5258 - 5264.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. K. Bishop, S. C. Wood, E. J. Eichwald, and C. G. Orosz
Immunobiology of Allograft Rejection in the Absence of IFN-{{gamma}}: CD8+ Effector Cells Develop Independently of CD4+ Cells and CD40-CD40 Ligand Interactions
J. Immunol., March 1, 2001; 166(5): 3248 - 3255.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. M. Rothstein, M. F. A. Livak, K. Kishimoto, C. Ariyan, H.-Y. Qian, S. Fecteau, M. Sho, S. Deng, X. X. Zheng, M. H. Sayegh, et al.
Targeting Signal 1 Through CD45RB Synergizes with CD40 Ligand Blockade and Promotes Long Term Engraftment and Tolerance in Stringent Transplant Models
J. Immunol., January 1, 2001; 166(1): 322 - 329.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Dai, B. T. Konieczny, and F. G. Lakkis
The Dual Role of IL-2 in the Generation and Maintenance of CD8+ Memory T Cells
J. Immunol., September 15, 2000; 165(6): 3031 - 3036.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Gorczynski, Z. Chen, D. A. Clark, J. Hu, G. Yu, X. Li, W. Tsang, and S. Hadidi
Regulation of Gene Expression of Murine MD-1 Regulates Subsequent T Cell Activation and Cytokine Production
J. Immunol., August 15, 2000; 165(4): 1925 - 1932.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Dai, A. Arakelov, M. Wagener, B. T. Konieczny, and F. G. Lakkis
The Role of the Common Cytokine Receptor {gamma}-Chain in Regulating IL-2-Dependent, Activation-Induced CD8+ T Cell Death
J. Immunol., September 15, 1999; 163(6): 3131 - 3137.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. C. Li, Y. Li, I. Dodge, A. D. Wells, X. X. Zheng, L. A. Turka, and T. B. Strom
Induction of Allograft Tolerance in the Absence of Fas-Mediated Apoptosis
J. Immunol., September 1, 1999; 163(5): 2500 - 2507.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Bushell, M. Niimi, P. J. Morris, and K. J. Wood
Evidence for Immune Regulation in the Induction of Transplantation Tolerance: A Conditional but Limited Role for IL-4
J. Immunol., February 1, 1999; 162(3): 1359 - 1366.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.